David W. Beier

Former Managing Director at Bay City Capital LLC

David W. Beier

David W. Beier

Former Managing Director at Bay City Capital LLC

Overview
RelSci Relationships

2619

Number of Boards

12

Birthday

1949

Age

72

Contact Data
Trying to get in touch with David W. Beier? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals David W. Beier likely has professional access to. A relationship does not necessarily indicate a personal connection.

General Counsel & Secretary at Optivia Biotechnology, Inc.

Relationship likelihood: Strong

President, Chief Executive Officer & Director at Nkarta, Inc.

Relationship likelihood: Strong

Chief Executive Officer & Chairman of the Board at Theravance Biopharma, Inc.

Relationship likelihood: Strong

Former Vice Chairman of the Board & Director at ARCA biopharma, Inc.

Relationship likelihood: Strong

Vice President-Strategy & Corporate Development at Edwards Lifesciences Corp.

Relationship likelihood: Strong

Chairman & Chief Executive Officer at Arcus Biosciences, Inc.

Relationship likelihood: Strong

CMO at Retrotope, Inc.

Relationship likelihood: Strong

President, Chief Executive Officer & Chairman at CytomX Therapeutics, Inc.

Relationship likelihood: Strong

Interim Chief Financial Officer at Precision BioSciences, Inc.

Relationship likelihood: Strong

Member of the Enlarged Corporate Executive Committee, Global Head Pharma Partnering at Roche Holding AG

Relationship likelihood: Strong

Paths to David W. Beier
Potential Connections via
Relationship Science
You
David W. Beier
Former Managing Director at Bay City Capital LLC
Education
J.D.
Class of 1973

Albany Law School is located in the heart of New York's capital, and is the oldest independent law school in North America. With more than 160 years of experience in law education, the law school's students and alumni embark on brilliant careers—a U.S. president, governors including New York's current governor, chief counsels to Fortune 500 companies, and seats on the U.S. Supreme Court. Albany Law's outstanding location—the only law school within 90 miles of New York's capital—offers unparalleled opportunities for law students. Albany, the home of New York's highest court, federal courts, and the state legislature, is itself a laboratory for the study of law. Albany Law School offers J.D. and LL.M. degrees, 14 concentrations and several joint degrees through accredited colleges and universities in the Capital Region and New York City. A wide array of field placements, including internships through the Albany Law Clinic & Justice Center and the Government Law Center, provide students essential hands-on learning. The Career Center assists students from their first day at Albany Law. With more than 10,000 alumni practicing in every state in the country, and several continents, Albany Law’s graduates serve as a vital community and resource for the law school and its students. Albany Law offers a close-knit community of dedicated students, accessible faculty and ample opportunities.

B.A.
Class of 1970

Founded in 1819, Colgate University is a highly selective residential liberal arts institution distinguished by academic excellence and interdisciplinary inquiry. Located on a beautiful campus in upstate New York, Colgate takes pride in the active engagement of its students and faculty in local, national, and global communities.

Career History
Managing Director
2013 - Current

Bay City Capital invests in both private and public life sciences companies located in the US. The firm targets companies operating in the fields of biopharmaceuticals, drug discovery, medical devices and diagnostics. They acts as lead/co-lead investor and provides financing for seed, early and later stage capital requirements. They takes a seat on the board of directors and makes co-investments.

Senior Vice President, Global Government & Corporate Affairs
2003 - 2013

Amgen, Inc. is a biotechnology medicines company, which discovers, develops, manufactures and markets medicines for grievous illnesses. The company focuses on human therapeutics and concentrates on innovating novel medicines based on advances in cellular and molecular biology. It markets recombinant protein therapeutics in supportive cancer care, nephrology and inflammation. The company's products include Neulasta, a pegylated protein, based on the Filgrastim molecule and NEUPOGEN, a recombinant-methionyl human granulocyte colony stimulating factor both of which selectively stimulate the production of neutrophils; Enbrel, an inhibitor of tumor necrosis factor, a substance that plays a role in the body's response to inflammatory diseases; Sensipar/Mimpara, a small molecule calcimimetic that lowers serum calcium levels; Vectibix, a monoclonal antibody that binds specifically to the epidermal growth factor receptor; and Nplate, a thrombopoietin receptor agonist that mimics endogenous TPO, the primary driver of platelet production. Amgen was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

Partner
1998 - 2001

Hogan & Hartson LLP provides legal services. Its is specialized in areas include energy, government contracts, immigration, and litigation. The company has offices in across Asia, Europe, Latin America and North America. Hogan & Hartston was founded in 1904 and is headquartered in Washington, DC.

Boards & Committees
Director
Prior

The Amgen Foundation seeks to advance excellence in science education to inspire the next generation of innovators, and invest in strengthening communities where Amgen staff members live and work. The Foundation, established in 1991, is an integral component of Amgen’s commitment to dramatically improve people’s lives. The Foundation is the principal channel for Amgen’s corporate philanthropy. To date, the Foundation has contributed over $200 million to local, regional and international nonprofit organizations that reflect Amgen’s core values and complement the company’s dedication to impacting lives in inspiring and innovative ways. The Foundation places a strong emphasis on strengthening science education and is committed to investing in meaningful, evidence-based initiatives that make a difference at the local, national, and international levels. To that end, the Amgen Foundation has contributed over $100 million to advancing science education programming globally.

Board Member
Tenure Unconfirmed

The National Health Council (NHC) is a nonprofit association of health organizations Its members are national health-related organizations, including leading patient advocacy groups such as the American Cancer Society, the American Heart Association, the American Diabetes Association, and the Alzheimer's Association.

Political Donations
$1,000
2014
$500
2013
$750
2013
Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by David W. Beier. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of David W. Beier's profile does not indicate a business or promotional relationship of any kind between RelSci and David W. Beier.